NF1 and multiminicore myopathy: These genetic findings highlight potential molecular pathways, including the deletion of nitric oxide signaling (GUCY1A3), that could account for MMD (Herve et al., 2014) and activation of proliferative pathways (NF1) (Friedman et al., 2002).